No disease recurrences after short course of neoadjuvant immunotherapy, according to follow-up

Medical Xpress - latest medical and health news stories · 1h ago

A short course of neoadjuvant immunotherapy continues to show long-term outcomes in patients with locally advanced mismatch repair–deficient (dMMR) colon cancer. In the NICHE-2 study, none of the 111 patients in the primary efficacy population experienced disease recurrence, and all were alive at their most recent follow-up. The findings, now published in The Lancet, provide further evidence of…

Read original article on Medical Xpress - latest medical and health news stories →

No disease recurrences after short course of neoadjuvant immunotherapy, according to follow-up

Related news